About

Achim Lusch is a urologic surgeon and researcher whose work has significantly advanced the fields of robotic surgery, surgical education, and testicular cancer management. His research is centered on improving surgical outcomes through technological innovation and rigorous clinical trials. A key contribution is the PRIMETEST trial (over 90 citations), a landmark phase II study investigating primary retroperitoneal lymph node dissection (RPLND) as an alternative to chemotherapy or radiation for stage IIA/B seminoma, aiming to reduce treatment-related toxicity. Lusch has also been instrumental in evaluating surgical technologies, demonstrating that three-dimensional vision enhances laparoscopic performance (98 citations) and validating simulation tools like the da Vinci Trainer for robotic skill acquisition (90 citations). His work on robot-assisted radical prostatectomy includes long-term oncological outcomes (62 citations) and assessments of technical skill progression in urology residents. Through these studies, Lusch has helped shape modern urologic practice, balancing the adoption of new technologies with evidence-based approaches to cancer care and surgical training.

Research Focus

Key Achievements

7
H-Index
11
Papers
396
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Evaluation of the Impact of Three-Dimensional Vision on Laparoscopic Performance
98 citations · 2013
📈 Most Prolific Year: 2012 (3 Papers)
🤝 Key Collaborators: 35
🏛 Institutions: University of California, Irvine, Heinrich Heine University Düsseldorf, Hochschule Düsseldorf University of Applied Sciences

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago